BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37904679)

  • 1. Regulation of long noncoding RNAs in the pathogenesis and clinical implications of pituitary adenomas.
    Wang L; Xu D
    Immun Inflamm Dis; 2023 Oct; 11(10):e1047. PubMed ID: 37904679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas.
    Zhang T; Yang Z; Gao H
    J Neurooncol; 2017 Sep; 134(2):253-258. PubMed ID: 28577032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Long Noncoding RNAs in the Biology of Pituitary Adenomas.
    Beylerli O; Gareev I; Pavlov V; Chen X; Zhao S
    World Neurosurg; 2020 May; 137():252-256. PubMed ID: 31678448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of noncoding RNAs in pituitary adenoma.
    Bahreini F; Jabbari P; Gossing W; Aziziyan F; Frohme M; Rezaei N
    Epigenomics; 2021 Sep; 13(17):1421-1437. PubMed ID: 34558980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement of miRNAs in Pituitary Adenomas Pathogenesis and the Clinical Implications.
    Xu D; Wang L
    Eur Neurol; 2022; 85(3):171-176. PubMed ID: 35034033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress on lncRNA Functions and Mechanisms in Pituitary Adenomas.
    Du Q; Yao DS; Wang YW; Cheng C
    Horm Metab Res; 2020 May; 52(5):280-288. PubMed ID: 32403143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma.
    Rahimian N; Sheida A; Rajabi M; Heidari MM; Tobeiha M; Esfahani PV; Ahmadi Asouri S; Hamblin MR; Mohamadzadeh O; Motamedzadeh A; Khaksary Mahabady M
    Pathol Res Pract; 2023 Aug; 248():154649. PubMed ID: 37453360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma.
    Wu W; Cao L; Jia Y; Xiao Y; Zhang X; Gui S
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of lncRNA regulatory networks reveal the key lncRNAs associated with Pituitary adenomas progression.
    Xue YH; Ge YQ
    Math Biosci Eng; 2020 Jan; 17(3):2138-2149. PubMed ID: 32233527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
    Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
    Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway.
    Zhang R; Yang F; Fan H; Wang H; Wang Q; Yang J; Song T
    Cell Death Dis; 2021 May; 12(6):524. PubMed ID: 34021124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion.
    Li J; Qian Y; Zhang C; Wang W; Qiao Y; Song H; Li L; Guo J; Lu D; Deng X
    Cell Death Dis; 2021 Jun; 12(6):580. PubMed ID: 34091587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
    Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
    Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression analysis of necroptosis related genes and lncRNAs in patients with pituitary neuroendocrine tumors.
    Askari A; Darabi MR; Eslami S; Jamali E; Sharifi G; Ghafouri-Fard S; Dilmaghani NA
    Pathol Res Pract; 2024 Jun; 258():155332. PubMed ID: 38696856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-Transmitted lncRNA H19 Inhibits the Growth of Pituitary Adenoma.
    Zhang Y; Liu YT; Tang H; Xie WQ; Yao H; Gu WT; Zheng YZ; Shang HB; Wang Y; Wei YX; Wu ZR; Wu ZB
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6345-6356. PubMed ID: 31369093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of PVT1 and NEAT1 lncRNAs in pituitary adenomas.
    Ghafouri-Fard S; Abbasi F; Nicknam A; Hussen BM; Eslami S; Akbari Dilmaghani N; Taheri M; Sharifi G
    Pathol Res Pract; 2023 Aug; 248():154573. PubMed ID: 37270938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA-mRNA Expression Patterns in Invasive Pituitary Adenomas: A Microarray Analysis.
    Peng C; Wang S; Yu J; Deng X; Ye H; Chen Z; Yao H; Cai H; Li Y; Yuan Y
    Biomed Res Int; 2022; 2022():1380485. PubMed ID: 35572729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients.
    Guaraldi F; Morandi L; Zoli M; Mazzatenta D; Righi A; Evangelisti S; Ambrosi F; Tonon C; Giannini C; Lloyd RV; Asioli S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):763-772. PubMed ID: 36161330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.